27 Feb 2026
07:30 CET |
GIMV |
Share buyback – update
|
30202010 Asset Managers and Custodians |
Other subject |
27 Feb 2026
07:30 CET |
GIMV |
Share buyback – update
|
30202010 Asset Managers and Custodians |
Other subject |
27 Feb 2026
07:30 CET |
GIMV |
Inkoop eigen aandelen – update
|
30202010 Asset Managers and Custodians |
Other subject |
20 Feb 2026
07:30 CET |
GIMV |
Announcement of share buyback in the context of a share purchase plan
|
30202010 Asset Managers and Custodians |
Other subject |
20 Feb 2026
07:30 CET |
GIMV |
Announcement of share buyback in the context of a share purchase plan
|
30202010 Asset Managers and Custodians |
Other subject |
20 Feb 2026
07:30 CET |
GIMV |
Aankondiging inkoop eigen aandelen in het kader van een aandelenaankoopplan
|
30202010 Asset Managers and Custodians |
Other subject |
19 Feb 2026
07:00 CET |
GIMV |
Gimv zet sterk groeitraject voort met solide resultaten Recordinvesteringen in boekjaar van 9 maanden
|
30202010 Asset Managers and Custodians |
Other subject |
19 Feb 2026
07:00 CET |
GIMV |
Gimv builds on strong growth to deliver solid results Record investment level in a shortened financial year of 9 months
|
30202010 Asset Managers and Custodians |
Other subject |
19 Feb 2026
07:00 CET |
GIMV |
Gimv builds on strong growth to deliver solid results Record investment level in a shortened financial year of 9 months
|
30202010 Asset Managers and Custodians |
Other subject |
26 Jan 2026
17:45 CET |
GIMV |
Gimv verhoogt focus op strategische doelstellingen en discontinueert activiteiten voor nieuwe Life Sciences investeringen
|
30202010 Asset Managers and Custodians |
Other subject |
26 Jan 2026
17:45 CET |
GIMV |
Gimv increases focus on strategic objectives and discontinues activities for new Life Sciences investments
|
30202010 Asset Managers and Custodians |
Other subject |
26 Jan 2026
17:45 CET |
GIMV |
Gimv increases focus on strategic objectives and discontinues activities for new Life Sciences investments
|
30202010 Asset Managers and Custodians |
Other subject |
26 Jan 2026
17:45 CET |
GIMV |
Gimv increases focus on strategic objectives and discontinues activities for new Life Sciences investments
|
30202010 Asset Managers and Custodians |
Other subject |
20 Jan 2026
07:30 CET |
GIMV |
Gimv leidt een Series B investeringsronde van EUR 51 miljoen in Exciva voor verdere ontwikkeling van een innovatieve Alzheimerbehandeling
|
30202010 Asset Managers and Custodians |
Other subject |
20 Jan 2026
07:30 CET |
GIMV |
Gimv leads € 51 million Series B investment round in Exciva to advance innovative Alzheimer’s therapy
|
30202010 Asset Managers and Custodians |
Other subject |
20 Jan 2026
07:30 CET |
GIMV |
Gimv leads € 51 million Series B investment round in Exciva to advance innovative Alzheimer’s therapy
|
30202010 Asset Managers and Custodians |
Other subject |
16 Jan 2026
07:30 CET |
GIMV |
Gimv verkoopt meerderheidsbelang in ALT Technologies aan CCL Industries
|
30202010 Asset Managers and Custodians |
Other subject |
16 Jan 2026
07:30 CET |
GIMV |
Gimv sells majority stake in ALT Technologies to CCL Industries
|
30202010 Asset Managers and Custodians |
Other subject |
16 Jan 2026
07:30 CET |
GIMV |
Gimv sells majority stake in ALT Technologies to CCL Industries
|
30202010 Asset Managers and Custodians |
Other subject |
27 Nov 2025
07:30 CET |
GIMV |
Gimv joins forces with CNP to accelerate the global expansion of Equine Care Group
|
30202010 Asset Managers and Custodians |
Other subject |
27 Nov 2025
07:30 CET |
GIMV |
Gimv joins forces with CNP to accelerate the global expansion of Equine Care Group
|
30202010 Asset Managers and Custodians |
Other subject |
27 Nov 2025
07:30 CET |
GIMV |
Gimv bundelt krachten met CNP om de wereldwijde expansie van Equine Care Group te versnellen
|
30202010 Asset Managers and Custodians |
Other subject |
20 Nov 2025
07:00 CET |
GIMV |
Solid growth performance in the first half of FY 2025
|
30202010 Asset Managers and Custodians |
Other subject |
20 Nov 2025
07:00 CET |
GIMV |
Solide groei in eerste helft boekjaar 2025
|
30202010 Asset Managers and Custodians |
Other subject |
20 Nov 2025
07:00 CET |
GIMV |
Solid growth performance in the first half of FY 2025
|
30202010 Asset Managers and Custodians |
Other subject |
05 Nov 2025
07:30 CET |
GIMV |
Gimv partners with Quality Guard to establish a leading software platform for food safety compliance across Europe
|
30202010 Asset Managers and Custodians |
Other subject |
05 Nov 2025
07:30 CET |
GIMV |
Gimv partners with Quality Guard to establish a leading software platform for food safety compliance across Europe
|
30202010 Asset Managers and Custodians |
Other subject |
05 Nov 2025
07:30 CET |
GIMV |
Gimv bundelt krachten met Quality Guard om een toonaangevend softwareplatform voor voedselveiligheid in Europa uit te bouwen
|
30202010 Asset Managers and Custodians |
Other subject |
22 Oct 2025
07:30 CEST |
GIMV |
Gimv Life Sciences realizes successful exit with the sale of its stake in Imcheck Therapeutics to Ipsen
|
30202010 Asset Managers and Custodians |
Other subject |
22 Oct 2025
07:30 CEST |
GIMV |
Gimv Life Sciences realiseert succesvolle exit met de verkoop van belang in Imcheck Therapeutics aan Ipsen.
|
30202010 Asset Managers and Custodians |
Other subject |
22 Oct 2025
07:30 CEST |
GIMV |
Gimv Life Sciences realizes successful exit with the sale of its stake in Imcheck Therapeutics to Ipsen
|
30202010 Asset Managers and Custodians |
Other subject |
26 Sep 2025
07:30 CEST |
GIMV |
Gimv and EGS Beteiligungen reinforce strategic support for Spineart with CHF 25 million capital increase to accelerate global growth
|
30202010 Asset Managers and Custodians |
Other subject |
26 Sep 2025
07:30 CEST |
GIMV |
Gimv and EGS Beteiligungen reinforce strategic support for Spineart with CHF 25 million capital increase to accelerate global growth
|
30202010 Asset Managers and Custodians |
Other subject |
26 Sep 2025
07:30 CEST |
GIMV |
Gimv en EGS Beteiligungen versterken hun strategische steun aan Spineart met kapitaalverhoging van 25 miljoen CHF ter versnelling van wereldwijde groei
|
30202010 Asset Managers and Custodians |
Other subject |
02 Sep 2025
07:00 CEST |
GIMV |
Trading update
|
30202010 Asset Managers and Custodians |
Other subject |
02 Sep 2025
07:00 CEST |
GIMV |
Trading update
|
30202010 Asset Managers and Custodians |
Other subject |
02 Sep 2025
07:00 CEST |
GIMV |
Trading update
|
30202010 Asset Managers and Custodians |
Other subject |
28 Aug 2025
07:30 CEST |
GIMV |
Gimv partners with Novicare to drive innovation and sustainable growth in specialized healthcare services.
|
30202010 Asset Managers and Custodians |
Other subject |
28 Aug 2025
07:30 CEST |
GIMV |
Gimv en Novicare bundelen hun krachten om duurzame groei en innovatie in gespecialiseerde zorgdiensten te stimuleren.
|
30202010 Asset Managers and Custodians |
Other subject |
28 Aug 2025
07:30 CEST |
GIMV |
Gimv partners with Novicare to drive innovation and sustainable growth in specialized healthcare services.
|
30202010 Asset Managers and Custodians |
Other subject |
30 Jul 2025
17:45 CEST |
GIMV |
Openbaarmaking van transparantiekennisgeving
|
30202010 Asset Managers and Custodians |
Other subject |
30 Jul 2025
17:45 CEST |
GIMV |
Publication of a transparency notification
|
30202010 Asset Managers and Custodians |
Other subject |
30 Jul 2025
17:45 CEST |
GIMV |
Publication of a transparency notification
|
30202010 Asset Managers and Custodians |
Other subject |
23 Jul 2025
17:45 CEST |
GIMV |
Résultat du dividende optionnel pour l\'exercice 2024-25: 64,2% des droits au dividende ont été distribués sous la forme de nouvelles actions ordinaires, résultant en une augmentation de capital de 41,8 millions d’euros.
|
30202010 Asset Managers and Custodians |
Other subject |
23 Jul 2025
17:45 CEST |
GIMV |
Resultaat van het keuzedividend over het boekjaar 2024-25: 64,2% van de dividendrechten worden uitgekeerd onder de vorm van nieuwe gewone aandelen, wat leidt tot een kapitaalverhoging van 41,8 miljoen EUR
|
30202010 Asset Managers and Custodians |
Other subject |
23 Jul 2025
17:45 CEST |
GIMV |
Outcome of the optional dividend for the FY 2024-25: 64.2% of the dividend rights are distributed in the form of new ordinary shares, resulting in a capital increase of EUR 41.8 million
|
30202010 Asset Managers and Custodians |
Other subject |
23 Jul 2025
07:45 CEST |
GIMV |
Gimv reinvests in the Bugaboo-Joolz combination after companies joining forces to accelerate growth in the worldwide stroller market
|
30202010 Asset Managers and Custodians |
Other subject |
23 Jul 2025
07:45 CEST |
GIMV |
Gimv herinvesteert in de Bugaboo-Joolz combinatie nadat bedrijven de krachten bundelen om groei in de wereldwijde kinderwagenmarkt te versnellen
|
30202010 Asset Managers and Custodians |
Other subject |
23 Jul 2025
07:45 CEST |
GIMV |
Gimv reinvests in the Bugaboo-Joolz combination after companies joining forces to accelerate growth in the worldwide stroller market
|
30202010 Asset Managers and Custodians |
Other subject |
22 Jul 2025
18:55 CEST |
GIMV |
Gimv invests in Hemink, a Dutch renovation and maintenance specialist with focus on sustainable real estate
|
30202010 Asset Managers and Custodians |
Other subject |